Project Grant HT94252510440
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$672K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $672,000 Project Grant to the Albert Einstein College of Medicine in Bronx, NY to support the "MRNA TRANSLATION AND IMMUNE RECOGNITION IN MYC-DRIVEN LYMPHOMA" research project. This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research initiatives to transform healthcare for military service members and the broader public. The 2-year project,...
The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military...
The Albert Einstein College of Medicine has been awarded a $882,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a novel targeted drug therapy to treat small cell lung cancer (SCLC). The award will support research activities from June 1, 2024 through May 31, 2027. As a highly experienced recipient of federal research grants and contracts, the college has a track record of conducting biomedical research and...
The Albert Einstein College of Medicine, a private non-profit educational institution in the Bronx, New York, has been awarded a $672,000 Project Grant by the Defense Health Agency, a component of the Department of Defense. The grant, which runs from March 1, 2024 to February 29, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420) and will support research on "Clonal Hematopoiesis as a Driver of Therapeutic Resistance and Metastatic Relapse in Breast...
The Albert Einstein College of Medicine has been awarded a $168,000 Project Grant from the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the role of alpha1-3/4 fucosyltransferases-mediated E-selectin function in the bone metastasis of prostate cancer. The project aims to advance scientific understanding and develop new treatment approaches for this form of cancer that disproportionately affects military service members...
The federal Project Grant award, titled "PROTEOMICS OF VASCULAR WALL AGING," was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $462,000.00 award, effective from Jan 1, 2025 to Dec 31, 2026, supports advanced biomedical research at Albert Einstein College of Medicine focused on investigating cellular mechanisms of vascular aging. As a prominent academic medical research center, Albert Einstein College of Medicine...
The Albert Einstein College of Medicine was awarded a $1,260,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into "A NOVEL IMMUNE CHECKPOINT PATHWAY IN HUMAN PROSTATE CANCER" from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative...
Albert Einstein College of Medicine (AECOM) was awarded a $672,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on Treatment-Induced Metastasis in Ewing Sarcoma. The two-year grant runs from June 1, 2023 to May 31, 2025 and will support AECOM's investigation into medical solutions for metastatic cancers affecting service members, in line with the program's goals of transforming military...
The Albert Einstein College of Medicine was awarded a $505,122 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through February 2024 to decipher the stemness code for breast cancer metastasis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health...
This Project Grant award of $1,723,552.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Beth Israel Deaconess Medical Center, Inc. (BIDMC) to target specific long non-coding RNAs (lncRNAs) in novel combined therapies. The goal is to modulate the TSP1-dependent immune microenvironment vulnerabilities in advanced thyroid cancer. The research, spanning from September 1, 2025 to August 31, 2028, aims to...